Please enable JavaScript to continue using this application.

Compare $ORGO vs $TARA | Chartloom

Compare

$ORGO vs $TARA

Organogenesis Holdings Inc · Protara Therapeutics Inc

ORGO

Organogenesis Holdings Inc

TARA

Protara Therapeutics Inc

Compare $ORGO vs $TARA

Comparing Organogenesis Holdings Inc and Protara Therapeutics Inc

ORGOOrganogenesis Holdings Inc

TARAProtara Therapeutics Inc

ORGOOrganogenesis Holdings Inc

Market cap

$166M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.74x

Rev growth (TTM)

6.5%

YTD performance

-72.2%

52W performance

-68.8%

FCF yield

12.6%

TARAProtara Therapeutics Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.8%

52W performance

-45.7%

FCF yield

-42.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ORGO

TARA

Detailed metrics comparison

ORGO

Organogenesis Holdings Inc

TARA

Protara Therapeutics Inc

Market Cap

ORGO$166M

TARA$155M

Enterprise Value

ORGO$132M

TARA$138M

Price

ORGO$1.29

TARA$2.76

P/E Ratio

ORGON/A

TARAN/A

P/S Ratio

ORGO0.36x

TARA0.00x

EV/Sales

ORGO0.29x

TARA0.00x

EV/EBITDA

ORGO7.37x

TARA0.00x

P/B Ratio

ORGO0.59x

TARA0.99x

P/FCF Ratio

ORGO7.96x

TARAN/A

EV/FCF

ORGO6.31x

TARA-2.07x

PEG Ratio

ORGON/A

TARAN/A

Forward P/E (NTM)

ORGON/A

TARAN/A

Forward P/S (NTM)

ORGO0.74x

TARAN/A

Revenue (TTM)

ORGO$457M

TARA$0

Revenue Growth (YoY)

ORGO6.5%

TARAN/A

Forward Rev Growth

ORGO37.6%

TARA5488.8%

Gross Margin (TTM)

ORGO70.4%

TARA0.0%

Operating Margin (TTM)

ORGO0.0%

TARA0.0%

EBITDA Margin (TTM)

ORGO-2.0%

TARA0.0%

Net Margin (TTM)

ORGO-23.1%

TARA0.0%

FCF Margin (TTM)

ORGO4.6%

TARAN/A

Net Income (TTM)

ORGO$-106M

TARA$-70M

FCF (TTM)

ORGO$21M

TARA$-66M

EPS (TTM)

ORGO-$0.82

TARA-$1.15

ROE (TTM)

ORGO-2260.0%

TARA-4172.0%

ROA (TTM)

ORGO-1654.0%

TARA-3878.0%

ROIC (TTM)

ORGO-2187.0%

TARA-4172.0%

Cash

ORGO$46M

TARA$17M

Debt

ORGO$12M

TARA$0

Net Cash/Debt

ORGO$34M

TARA$17M

Current Ratio (TTM)

ORGO3.52x

TARA10.97x

Quick Ratio (TTM)

ORGO2.66x

TARA10.81x

Debt/Equity (TTM)

ORGO0.04x

TARA0.00x

Debt/Assets (TTM)

ORGO0.0%

TARA0.0%

Interest Coverage (TTM)

ORGON/A

TARAN/A

Net Debt/EBITDA (TTM)

ORGO0.00x

TARA0.00x

Beta

ORGO1.44

TARA1.54

52W Performance

ORGO-68.8%

TARA-45.7%

YTD Performance

ORGO-72.2%

TARA-48.8%

% from 52W High

ORGO-81.8%

TARA-64.8%

% from 52W Low

ORGO3.2%

TARA9.8%

Asset Turnover (TTM)

ORGO0.90x

TARA0.00x

FCF Yield (TTM)

ORGO12.6%

TARA-42.9%

Earnings Yield (TTM)

ORGO-63.8%

TARA-45.2%

Dividend Yield (TTM)

ORGON/A

TARAN/A

Rule of 40

ORGO11.1

TARA0.0

EV/GP/RG

ORGO0.01

TARAN/A

Ticker research

View ORGO research View TARA research

Metric	ORGO Organogenesis Holdings Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$166M	$155M
Enterprise Value	$132M	$138M
Price	$1.29	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	0.36x	0.00x
EV/Sales	0.29x	0.00x
EV/EBITDA	7.37x	0.00x
P/B Ratio	0.59x	0.99x
P/FCF Ratio	7.96x	N/A
EV/FCF	6.31x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.74x	N/A
Revenue & Growth
Revenue (TTM)	$457M	$0
Revenue Growth (YoY)	6.5%	N/A
Forward Rev Growth	37.6%	5488.8%
Profitability
Gross Margin (TTM)	70.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2.0%	0.0%
Net Margin (TTM)	-23.1%	0.0%
FCF Margin (TTM)	4.6%	N/A
Net Income (TTM)	$-106M	$-70M
FCF (TTM)	$21M	$-66M
EPS (TTM)	-$0.82	-$1.15
ROE (TTM)	-2260.0%	-4172.0%
ROA (TTM)	-1654.0%	-3878.0%
ROIC (TTM)	-2187.0%	-4172.0%
Financial Health
Cash	$46M	$17M
Debt	$12M	$0
Net Cash/Debt	$34M	$17M
Current Ratio (TTM)	3.52x	10.97x
Quick Ratio (TTM)	2.66x	10.81x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	1.54
52W Performance	-68.8%	-45.7%
YTD Performance	-72.2%	-48.8%
% from 52W High	-81.8%	-64.8%
% from 52W Low	3.2%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.90x	0.00x
FCF Yield (TTM)	12.6%	-42.9%
Earnings Yield (TTM)	-63.8%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	11.1	0.0
EV/GP/RG	0.01	N/A
Ticker research	View ORGO research	View TARA research

Valuation

P/S Ratio

TARA

0.00x

ORGO

0.36x

EV/FCF

TARA

-2.07x

ORGO

6.31x

Growth & revenue

Revenue Growth TTM

ORGO

6.5%

Forward Revenue Growth

TARA

5488.8%

ORGO

37.6%

Profitability & performance

Gross Margin

ORGO

70.4%

TARA

0.0%

ROE

ORGO

-2260.0%

TARA

-4172.0%

FCF Yield %

ORGO

12.6%

TARA

-42.9%

52-Week Performance

TARA

-45.7%

ORGO

-68.8%

Detailed metrics comparison

ORGO

Organogenesis Holdings Inc

TARA

Protara Therapeutics Inc

Market Cap

ORGO$166M

TARA$155M

Enterprise Value

ORGO$132M

TARA$138M

Price

ORGO$1.29

TARA$2.76

P/E Ratio

ORGON/A

TARAN/A

P/S Ratio

ORGO0.36x

TARA0.00x

EV/Sales

ORGO0.29x

TARA0.00x

EV/EBITDA

ORGO7.37x

TARA0.00x

P/B Ratio

ORGO0.59x

TARA0.99x

P/FCF Ratio

ORGO7.96x

TARAN/A

EV/FCF

ORGO6.31x

TARA-2.07x

PEG Ratio

ORGON/A

TARAN/A

Forward P/E (NTM)

ORGON/A

TARAN/A

Forward P/S (NTM)

ORGO0.74x

TARAN/A

Revenue (TTM)

ORGO$457M

TARA$0

Revenue Growth (YoY)

ORGO6.5%

TARAN/A

Forward Rev Growth

ORGO37.6%

TARA5488.8%

Gross Margin (TTM)

ORGO70.4%

TARA0.0%

Operating Margin (TTM)

ORGO0.0%

TARA0.0%

EBITDA Margin (TTM)

ORGO-2.0%

TARA0.0%

Net Margin (TTM)

ORGO-23.1%

TARA0.0%

FCF Margin (TTM)

ORGO4.6%

TARAN/A

Net Income (TTM)

ORGO$-106M

TARA$-70M

FCF (TTM)

ORGO$21M

TARA$-66M

EPS (TTM)

ORGO-$0.82

TARA-$1.15

ROE (TTM)

ORGO-2260.0%

TARA-4172.0%

ROA (TTM)

ORGO-1654.0%

TARA-3878.0%

ROIC (TTM)

ORGO-2187.0%

TARA-4172.0%

Cash

ORGO$46M

TARA$17M

Debt

ORGO$12M

TARA$0

Net Cash/Debt

ORGO$34M

TARA$17M

Current Ratio (TTM)

ORGO3.52x

TARA10.97x

Quick Ratio (TTM)

ORGO2.66x

TARA10.81x

Debt/Equity (TTM)

ORGO0.04x

TARA0.00x

Debt/Assets (TTM)

ORGO0.0%

TARA0.0%

Interest Coverage (TTM)

ORGON/A

TARAN/A

Net Debt/EBITDA (TTM)

ORGO0.00x

TARA0.00x

Beta

ORGO1.44

TARA1.54

52W Performance

ORGO-68.8%

TARA-45.7%

YTD Performance

ORGO-72.2%

TARA-48.8%

% from 52W High

ORGO-81.8%

TARA-64.8%

% from 52W Low

ORGO3.2%

TARA9.8%

Asset Turnover (TTM)

ORGO0.90x

TARA0.00x

FCF Yield (TTM)

ORGO12.6%

TARA-42.9%

Earnings Yield (TTM)

ORGO-63.8%

TARA-45.2%

Dividend Yield (TTM)

ORGON/A

TARAN/A

Rule of 40

ORGO11.1

TARA0.0

EV/GP/RG

ORGO0.01

TARAN/A

Ticker research

View ORGO research View TARA research

Metric	ORGO Organogenesis Holdings Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$166M	$155M
Enterprise Value	$132M	$138M
Price	$1.29	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	0.36x	0.00x
EV/Sales	0.29x	0.00x
EV/EBITDA	7.37x	0.00x
P/B Ratio	0.59x	0.99x
P/FCF Ratio	7.96x	N/A
EV/FCF	6.31x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.74x	N/A
Revenue & Growth
Revenue (TTM)	$457M	$0
Revenue Growth (YoY)	6.5%	N/A
Forward Rev Growth	37.6%	5488.8%
Profitability
Gross Margin (TTM)	70.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2.0%	0.0%
Net Margin (TTM)	-23.1%	0.0%
FCF Margin (TTM)	4.6%	N/A
Net Income (TTM)	$-106M	$-70M
FCF (TTM)	$21M	$-66M
EPS (TTM)	-$0.82	-$1.15
ROE (TTM)	-2260.0%	-4172.0%
ROA (TTM)	-1654.0%	-3878.0%
ROIC (TTM)	-2187.0%	-4172.0%
Financial Health
Cash	$46M	$17M
Debt	$12M	$0
Net Cash/Debt	$34M	$17M
Current Ratio (TTM)	3.52x	10.97x
Quick Ratio (TTM)	2.66x	10.81x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	1.54
52W Performance	-68.8%	-45.7%
YTD Performance	-72.2%	-48.8%
% from 52W High	-81.8%	-64.8%
% from 52W Low	3.2%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.90x	0.00x
FCF Yield (TTM)	12.6%	-42.9%
Earnings Yield (TTM)	-63.8%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	11.1	0.0
EV/GP/RG	0.01	N/A
Ticker research	View ORGO research	View TARA research